Racial differences in anxiety, depression, and quality of life in women with polycystic ovary syndrome

• Published in: F&S Reports (Online) Vol. 2; no. 2; pp. 230 - 237
• Main Authors: Alur-Gupta, Snigdha, Lee, Iris, Chemerinski, Anat, Liu, Chang, Lipson, Jenna, Allison, Kelly, Gallop, Robert, Dokras, Anuja
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.06.2021; Elsevier
• Subjects: Anxiety; depression; Original; PCOS; quality of life; racial differences; PCOS; Anxiety; depression; quality of life; racial differences
• ISSN: 2666-3341; 2666-3341
• DOI: 10.1016/j.xfre.2021.03.003

To evaluate racial differences in the anxiety and depression prevalence and scores in women with polycystic ovary syndrome (PCOS). Cross-sectional. Academic institution. Reproductive-aged women with PCOS (n = 272) and controls (n = 295). Hospital anxiety and depression scale and modified PCOS quality-of-life survey (MPCOS-Q). Differences in depression and anxiety scores and quality-of-life score measured using the hospital anxiety and depression scale and MPCOS-Q were determined between White and Black women with PCOS. Multivariable correlation regressions assessed the association of the Ferriman-Gallwey score, total testosterone, body mass index (BMI), and homeostatic model assessment of insulin resistance with anxiety, depression, and quality-of-life scores. Multivariable regression controlling for age, BMI, and socioeconomic status showed that White women with PCOS had a significantly higher prevalence of anxiety than Black women with PCOS (75.9% vs. 61.3%) and significantly higher anxiety scores (mean ± SD, 10.3 ± 4.1 vs. 8.7 ± 4.6). The prevalence of depression (24.4% vs. 29%) and depression scores (4.8 ± 3.6 vs. 5.1 ± 4.0) was not significantly different. In multivariable correlation regressions, the interaction between BMI and race in its association with anxiety scores was significant. The association of race with Ferriman-Gallwey score, total testosterone, or homeostatic model assessment of insulin resistance was not significant. In multivariable models, although the total MPCOS-Q scores were similar, the infertility domain was significantly lower in Black women with PCOS (mean ± SD, 12.6 ± 7.8 vs. 17.5 ± 6.8) indicating a lower quality of life related to infertility. Racial differences identified in the prevalence of anxiety and MPCOS-Q domains suggest the importance of routine screening and provide an opportunity for targeted interventions based on race.